CSIMarket Company Name, Ticker, Customers, else..
 
• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Baxter International Inc   (BAX)
Other Ticker:  
 

Baxter International Inc 's Working Capital Per Sales

BAX's Working Capital and Revenue growth



BAX Working Capital Per Revenue (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Working Capital Change 0.9 % -9.1 % -5.17 % 42 % -38.48 %
Y / Y Revenue Change 2.83 % -1.56 % -3.55 % -1.72 % -1.04 %
Working Capital Per Revenue 0.24 0.24 0.25 0.25 0.22
Total Ranking # 993 # 1455 # 259 # 1481 # 1412
Seq. Working Capital Change -18.88 % -2 % -46.83 % 138.73 % -26.92 %
Seq. Revenue Change 6.12 % -4.19 % 1.11 % 0.03 % 1.59 %


New: More BAX's historic Working Capital Per Revenue Ratios >>


See BAX Capital expenditures by quarter >> Back to BAX Financial Strength Comparisons >> See BAX Balance Sheets

Comment on BAX's Working Capital Per Revenue in the second quarter 2024
Working Capital Per Revenue remained unchanged in the second quarter 2024 relative to previous quarter at 0.24

Within Healthcare sector 12 other companies have achieved lower Working Capital Per Revenue during the Q2 2024. While Baxter International Inc Working Capital Per Revenue overall ranking has impoved so far in the Q2 2024 to 993, from total ranking in the first quarter 2024 at 1455.
Working Capital Per Revenue Ranking
Within: No.
Industry # 4
Sector # 13
S&P 500 # 993


Working Capital Per Revenue Statistics
High Average Low
0.64
0.32
0.14
(June 30. 2016)   (Dec. 29. 2005)



Financial Statements
Baxter International Inc 's Working Capital $ 2,462 Millions Visit BAX's Balance sheet
Baxter International Inc 's Revenues $ 3,812 Millions Visit BAX's Income Statement
Where are BAX's Sales coming from? Visit BAX's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Jun 30 2024, within Healthcare Sector Working Capital Per Revenue
Irhythm Technologies Inc   0.66 
Amicus Therapeutics inc   0.66 
Venus Concept Inc   0.65 
Kiniksa Pharmaceuticals International Plc  0.62 
Lantheus Holdings Inc   0.62 
Exagen Inc   0.62 
Merit Medical Systems Inc  0.62 
Acutus Medical Inc   0.62 
Protalix Biotherapeutics inc   0.62 
Electromed Inc   0.62 
Insulet Corporation  0.61 
Pacira Biosciences inc   0.61 
Artivion Inc   0.60 
Assertio Holdings inc   0.59 
Veracyte Inc   0.59 
Paragon 28 inc   0.58 
Globus Medical Inc   0.58 
Livanova Plc  0.57 
  0.57 
Biolife Solutions Inc   0.56 
  0.55 
Atrion Corporation  0.55 
Elanco Animal Health Inc  0.55 
Integra Lifesciences Holdings Corp  0.53 
Ontrak Inc   0.53 
Nuo Therapeutics Inc   0.53 
Reshape Lifesciences Inc   0.52 
Koru Medical Systems Inc   0.50 
Mallinckrodt Plc  0.50 
Neurocrine Biosciences Inc   0.50 
Date modified: 2024-08-07T19:52:45+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com